Page 128 - 《中国药房》2025年10期

（Suppl.）：S86-S94. naltrexone in unemployed opioid-dependent adults：a ran‐
[ 8 ] MADISON K M，VOLPP K G，HALPERN S D. The law， domized controlled trial[J]. Addiction，2011，106（7）：
policy，and ethics of employers’ use of financial incen‐ 1309-1318.
tives to improve health[J]. J Law Med Ethics，2011，39 [22] ROSEN M I，DIECKHAUS K，MCMAHON T J，et al. Im‐
（3）：450-468. proved adherence with contingency management[J]. AIDS
[ 9 ] ANDRAKA-CHRISTOU B，WILLIAMS M，BUKSBAUM Patient Care STDS，2007，21（1）：30-40.
S，et al. US state laws relevant to incentives for health [23] BARNETT P G，SORENSEN J L，WONG W，et al. Effect
behavior：a qualitative analysis[J]. Prev Med，2023，176： of incentives for medication adherence on health care use
107645. and costs in methadone patients with HIV[J]. Drug Alco‐
[10] VLAEV I，KING D，DOLAN P，et al. The theory and hol Depend，2009，100（1/2）：115-121.
practice of “nudging”：changing health behaviors[J]. Pub‐ [24] BOONMANUNT S ， PATTANAPRATEEP O ，
lic Adm Rev，2016，76（4）：550-561. ONGPHIPHADHANAKUL B，et al. Evaluation of the
[11] GILES E L，ROBALINO S，MCCOLL E，et al. The effec‐ effectiveness of behavioral economic incentive programs
tiveness of financial incentives for health behaviour for goal achievement on healthy diet，weight control and
change：systematic review and meta-analysis[J]. PLoS physical activity：a systematic review and network meta-
One，2014，9（3）：e90347. analysis[J]. Ann Behav Med，2023，57（4）：277-287.
[12] ABRAHAM C，MICHIE S. A taxonomy of behavior [25] HAFF N，PATEL M S，LIM R，et al. The role of beha-
change techniques used in interventions[J]. Health Psy‐ vioral economic incentive design and demographic charac‐
chol，2008，27（3）：379-387. teristics in financial incentive-based approaches to chan-
[13] VLAEV I，KING D，DARZI A，et al. Changing health be‐ ging health behaviors：a meta-analysis[J]. Am J Health
haviors using financial incentives：a review from beha- Promot，2015，29（5）：314-323.
vioral economics[J]. BMC Public Health，2019，19（1）： [26] ALSAN M，BESHEARS J，ARMSTRONG W S，et al. A
1059. commitment contract to achieve virologic suppression in
[14] VOLPP K G，LOEWENSTEIN G，TROXEL A B，et al. A poorly adherent patients with HIV/AIDS[J]. AIDS，2017，
test of financial incentives to improve warfarin adherence 31（12）：1765-1769.
[J]. BMC Health Serv Res，2008，8：272. [27] KIMMEL S E，TROXEL A B，LOEWENSTEIN G，et al.
[15] HIGGINS S T，HEIL S H，LUSSIER J P. Clinical implica‐ Randomized trial of lottery-based incentives to improve
tions of reinforcement as a determinant of substance use warfarin adherence[J]. Am Heart J，2012，164（2）：
disorders[J]. Annu Rev Psychol，2004，55：431-461. 268-274.
[16] THORNTON R L. The demand for，and impact of，lear- [28] GILES E L，ROBALINO S，SNIEHOTTA F F，et al. Ac‐
ning HIV status[J]. Am Econ Rev，2008，98（5）：1829- ceptability of financial incentives for encouraging uptake
1863. of healthy behaviours：a critical review using systematic
[17] JOHNSTON M，SNIEHOTTA F. Financial incentives to methods[J]. Prev Med，2015，73：145-158.
change patient behaviour[J]. J Health Serv Res Policy， [29] HUF S W，VOLPP K G，ASCH D A，et al. Association of
2010，15（3）：131-132. medicaid healthy behavior incentive programs with smo-
[18] ADAMS J，GILES E L，MCCOLL E，et al. Carrots，sticks king cessation，weight loss，and annual preventive health
and health behaviours：a framework for documenting the visits[J]. JAMA Netw Open，2018，1（8）：e186185.
complexity of financial incentive interventions to change [30] HOSKINS K，ULRICH C M，SHINNICK J，et al. Accep-
health behaviours[J]. Health Psychol Rev，2014，8（3）： tability of financial incentives for health-related behavior
286-295. change：an updated systematic review[J]. Prev Med，2019，
[19] GRABO-WSKI J，O’BRIEN C P，GREENSTEIN R，et al. 126：105762.
Effects of contingent payment on compliance with a nal- [31] BECKER F，ANOKYE N，DE BEKKER-GROB E W，et
trexone regimen[J]. Am J Drug Alcohol Abuse，1979，6 al. Women’s preferences for alternative financial incen‐
（3）：355-365. tive schemes for breastfeeding：a discrete choice experi‐
[20] DEFULIO A，EVERLY J J，LEOUTSAKOS J S，et al. ment[J]. PLoS One，2018，13（4）：e0194231.
Employment-based reinforcement of adherence to an FDA [32] GILES E L，SNIEHOTTA F F，MCCOLL E，et al. Accepta-
approved extended release formulation of naltrexone in bility of financial incentives and penalties for encoura-
opioid-dependent adults：a randomized controlled trial[J]. ging uptake of healthy behaviours：focus groups[J]. BMC
Drug Alcohol Depend，2012，120（1/2/3）：48-54. Public Health，2015，15：58.
[21] EVERLY J J，DEFULIO A，KOFFARNUS M N，et al. （收稿日期：2024-09-23 修回日期：2025-04-16）
Employment-based reinforcement of adherence to depot （编辑：孙 冰）

· 1270 · China Pharmacy 2025 Vol. 36 No. 10 中国药房 2025年第36卷第10期